These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 204085)

  • 1. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
    Black CD; Watson GJ; Ward RJ
    Trans R Soc Trop Med Hyg; 1977; 71(6):550-2. PubMed ID: 204085
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1985 May; 33(5):379-80. PubMed ID: 2995305
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of allopurinol and pentostam in the treatment of visceral leishmaniasis.
    Tobaigy M; Mejer J; Peitersen B; Ansari M; Poll P
    Adv Exp Med Biol; 1986; 195 Pt A():471-3. PubMed ID: 3014837
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of experimental cutaneous leishmaniasis by liposome-entrapped Pentostam.
    New RR; Chance ML
    Acta Trop; 1980 Sep; 37(3):253-6. PubMed ID: 6106363
    [No Abstract]   [Full Text] [Related]  

  • 5. Liposomal dosage form development--some practical considerations.
    Rao LS
    J Parenter Sci Technol; 1983; 37(3):72-5. PubMed ID: 6308198
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of some drugs on Leishmania donovani in the golden hamster, Mesocricetus auratus.
    Al-Khateeb GH; Molan AL
    Chemotherapy; 1981; 27(2):117-25. PubMed ID: 6110518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis.
    Hunter CA; Dolan TF; Coombs GH; Baillie AJ
    J Pharm Pharmacol; 1988 Mar; 40(3):161-5. PubMed ID: 2899143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.
    Murray HW; Berman JD; Wright SD
    J Infect Dis; 1988 May; 157(5):973-8. PubMed ID: 2834469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileishmanial activity of antimonials entrapped in liposomes.
    New RR; Chance ML; Thomas SC; Peters W
    Nature; 1978 Mar; 272(5648):55-6. PubMed ID: 203863
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentostam the drug of choice in visceral leishmaniasis in Egypt.
    Soliman MS; Morsy TA; Abdel Messih MS; el Missiry AG
    J Egypt Soc Parasitol; 1984 Dec; 14(2):311-20. PubMed ID: 6096451
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of visceral leishmaniasis in Bihar.
    Thakur CP
    Trop Doct; 1986 Oct; 16(4):146-7. PubMed ID: 3022433
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment for visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1987 Sep; 35(9):641-3. PubMed ID: 2830224
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
    Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH
    Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium antimony resistant cases of kala-azar in and around Patna (south Bihar).
    Sehgal PN; Murmu C; Chatteyee AK
    J Commun Dis; 1988 Jun; 20(2):161-2. PubMed ID: 2853714
    [No Abstract]   [Full Text] [Related]  

  • 16. Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.
    Murray HW; Oca MJ; Granger AM; Schreiber RD
    J Clin Invest; 1989 Apr; 83(4):1253-7. PubMed ID: 2539396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
    Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC
    East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles.
    Guru PY; Agrawal AK; Singha UK; Singhal A; Gupta CM
    FEBS Lett; 1989 Mar; 245(1-2):204-8. PubMed ID: 2538359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 20. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.